B Liedtke

415 total citations
5 papers, 20 citations indexed

About

B Liedtke is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Pharmaceutical Science. According to data from OpenAlex, B Liedtke has authored 5 papers receiving a total of 20 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Pharmaceutical Science. Recurrent topics in B Liedtke's work include Breast Cancer Treatment Studies (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Genomics and Diagnostics (1 paper). B Liedtke is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Genomics and Diagnostics (1 paper). B Liedtke collaborates with scholars based in Germany and United States. B Liedtke's co-authors include Steven Shak, Kristina Lübbe, Ulrike Nitz, Stephan Henschen, Oleg Gluz, Christoph Uleer, Michael Clemens, Bahriye Aktas, H. Kreipe and I. Zuna and has published in prestigious journals such as Cancer Research, European Journal of Drug Metabolism and Pharmacokinetics and PubMed.

In The Last Decade

B Liedtke

5 papers receiving 17 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Liedtke Germany	3	11	5	5	4	4	5	20
Beth Hermes Germany	2	9 0.8×	5 1.0×	4 0.8×	4 1.0×	4 1.0×	2	23
M Calafato United Kingdom	3	16 1.5×	2 0.4×	6 1.2×	8 2.0×	6 1.5×	5	39
Bong-Jo Kim United States	2	10 0.9×	6 1.2×	2 0.4×	7 1.8×		2	19
Andreas Helminen Finland	2	8 0.7×	3 0.6×	3 0.6×		3 0.8×	2	24
Chu Chen United States	3	18 1.6×	2 0.4×	2 0.4×	3 0.8×	2 0.5×	3	37
Mohammad Sadegh Razeghinia Iran	3	10 0.9×	10 2.0×	2 0.4×	5 1.3×	3 0.8×	3	42
Ningling Wang China	4	19 1.7×	4 0.8×	8 1.6×	3 0.8×	2 0.5×	12	45
Kiyomi Kaneki Japan	2	18 1.6×	6 1.2×	3 0.6×	5 1.3×	2 0.5×	3	46
Robin De Putter Belgium	4	7 0.6×	3 0.6×	5 1.0×	8 2.0×	7 1.8×	6	33

Countries citing papers authored by B Liedtke

Since Specialization

Citations

This map shows the geographic impact of B Liedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Liedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Liedtke more than expected).

Fields of papers citing papers by B Liedtke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Liedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Liedtke. The network helps show where B Liedtke may publish in the future.

Co-authorship network of co-authors of B Liedtke

This figure shows the co-authorship network connecting the top 25 collaborators of B Liedtke. A scholar is included among the top collaborators of B Liedtke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Liedtke. B Liedtke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Gluz, Oleg, Matthias Christgen, C Liedtke, et al.. (2012). Abstract P2-10-08: Prospective comparison of Recurrence Score and different definitions of luminal subtypes by central pathology assessment of single markers in early breast cancer: results from the phase III WSG-planB Trial. Cancer Research. 72(24_Supplement). P2–10. 3 indexed citations

2.

Gluz, Oleg, B Liedtke, Bahriye Aktas, et al.. (2011). P5-18-03: First Interim Toxicity Analysis of the Randomized Phase III WSG Plan B Trial Comparing 4xEC-4xDoc Versus 6xTC in Breast Cancer Patients with HER2 Negative Breast Cancer (BC).. Cancer Research. 71(24_Supplement). P5–18. 1 indexed citations

3.

Gluz, Oleg, H. Kreipe, Matthias Christgen, et al.. (2010). Abstract P3-10-12: Pilot Phase of the Randomized PlanB Trial: Prospective Comparison of Molecular Classification, Oncotype DX® and Clinical-Pathological Characteristics in Hormone-Receptor (HR) Positive Primary Breast Cancer. Cancer Research. 70(24_Supplement). P3–10. 1 indexed citations

4.

Liedtke, B, et al.. (1985). Metabolism of thymoxamine I. Studies with14C-thymoxamine in rats. European Journal of Drug Metabolism and Pharmacokinetics. 10(1). 61–69. 13 indexed citations

5.

Liedtke, B, et al.. (1977). [Metabolism of Etozolin in rat, dog and man].. PubMed. 27(9a). 1776–85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact